Tirzepitide
$120.00Price
Tirzepatide is a dual agonist peptide that targets both GIP and GLP-1 receptors, primarily studied for metabolic and weight management applications.
Key research areas include:
Significant body weight reduction
Improved glycemic control and insulin sensitivity
Appetite regulation and energy balance
Treatment of type 2 diabetes and obesity
Potential benefits on cardiometabolic markers
It is investigated as a dual incretin mimetic with stronger effects on weight loss and glucose regulation compared to selective GLP-1 agonists.
